These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. In vivo thickness measurement of basal cell carcinoma and actinic keratosis with optical coherence tomography and 20-MHz ultrasound. Mogensen M; Nürnberg BM; Forman JL; Thomsen JB; Thrane L; Jemec GB Br J Dermatol; 2009 May; 160(5):1026-33. PubMed ID: 19183171 [TBL] [Abstract][Full Text] [Related]
6. The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions. Cannon PS; O'Donnell B; Huilgol SC; Selva D Br J Ophthalmol; 2011 Dec; 95(12):1682-5. PubMed ID: 20702431 [TBL] [Abstract][Full Text] [Related]
7. Imiquimod induces sustained remission of actinic damage: a case report spanning one decade of observation. Knackstedt TJ; Quitadamo M Cutis; 2015 Feb; 95(2):E20-3. PubMed ID: 25750973 [TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomography of actinic keratoses and basal cell carcinomas - differentiation by quantification of signal intensity and layer thickness. Schuh S; Kaestle R; Sattler EC; Welzel J J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1321-6. PubMed ID: 26915996 [TBL] [Abstract][Full Text] [Related]
9. Local reactions to imiquimod in the treatment of basal cell carcinoma. Tandon Y; Brodell RT Dermatol Online J; 2012 Sep; 18(9):1. PubMed ID: 23031368 [TBL] [Abstract][Full Text] [Related]
10. Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer. Akkilic-Materna M; Massone C; Komericki P Acta Derm Venereol; 2011 Jun; 91(4):432-5. PubMed ID: 21547348 [TBL] [Abstract][Full Text] [Related]
11. Patient Perception of Imiquimod Treatment for Actinic Keratosis and Superficial Basal Cell Carcinoma in 202 Patients. Waalboer-Spuij R; Holterhues C; van Hattem S; Schuttelaar ML; Gaastra MT; Kuijpers DI; Hollestein LM; Nijsten TE Dermatology; 2015; 231(1):56-62. PubMed ID: 25925162 [TBL] [Abstract][Full Text] [Related]
12. Assessment of optical coherence tomography imaging in the diagnosis of non-melanoma skin cancer and benign lesions versus normal skin: observer-blinded evaluation by dermatologists and pathologists. Mogensen M; Joergensen TM; Nürnberg BM; Morsy HA; Thomsen JB; Thrane L; Jemec GB Dermatol Surg; 2009 Jun; 35(6):965-72. PubMed ID: 19397661 [TBL] [Abstract][Full Text] [Related]
14. High-definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma. Boone MA; Marneffe A; Suppa M; Miyamoto M; Alarcon I; Hofmann-Wellenhof R; Malvehy J; Pellacani G; Del Marmol V J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1606-15. PubMed ID: 25656269 [TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography of basal cell carcinoma: density and signal attenuation. Yücel D; Themstrup L; Manfredi M; Jemec GB Skin Res Technol; 2016 Nov; 22(4):497-504. PubMed ID: 27264340 [TBL] [Abstract][Full Text] [Related]
16. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma. Vidal D; Matías-Guiu X; Alomar A Clin Exp Dermatol; 2004 Sep; 29(5):518-25. PubMed ID: 15347339 [TBL] [Abstract][Full Text] [Related]
17. The use of imiquimod in the treatment of periocular tumours. Ross AH; Kennedy CT; Collins C; Harrad RA Orbit; 2010 Apr; 29(2):83-7. PubMed ID: 20394545 [TBL] [Abstract][Full Text] [Related]
18. Machine-learning classification of non-melanoma skin cancers from image features obtained by optical coherence tomography. Jørgensen TM; Tycho A; Mogensen M; Bjerring P; Jemec GB Skin Res Technol; 2008 Aug; 14(3):364-9. PubMed ID: 19159385 [TBL] [Abstract][Full Text] [Related]
19. Optical coherence tomography and its role for delineating the thickness of keratinocyte dysplasia and neoplasia. Themstrup L; Jemec GB Curr Probl Dermatol; 2015; 46():95-100. PubMed ID: 25561212 [TBL] [Abstract][Full Text] [Related]
20. High-definition optical coherence tomography algorithm for discrimination of basal cell carcinoma from clinical BCC imitators and differentiation between common subtypes. Boone MA; Suppa M; Pellacani G; Marneffe A; Miyamoto M; Alarcon I; Ruini C; Hofmann-Wellenhof R; Malvehy J; Jemec GB; Del Marmol V J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1771-80. PubMed ID: 25712021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]